Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

825 studies match

clinicaltrialsPublishedShowing 151–200 of 825 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04430738	Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers	active not recruiting	Phase 2	40	Seagen, a wholly owned subsidiary of PfizerINDUSTRY	2	Feb 24, 2026	clinicaltrials
NCT04697628	Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer(innovaTV 301)	completed	Phase 3	502	Seagen, a wholly owned subsidiary of PfizerINDUSTRY